ArticleCurrent oncology (Toronto, Ont.)2026

Prognostic Value of Baseline Systemic Immune-Inflammation Index in Advanced Intrahepatic Cholangiocarcinoma Treated with First-Line Gemcitabine-Cisplatin Plus PD-L1 Inhibitor: A Single-Center Retrospective Study.

Shuan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.